Clinical Trial

Randomized Controlled Study of Dragonfly System for Functional Mitral Regurgitation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To confirm the effectiveness and safety of the Dragonfly transcatheter mitral valve repair system for the treatment of chronic moderate to severe (3+) or severe (4+) functional mitral regurgitation (FMR) who remained clinically symptomatic after adequate treatment.
Trial Details
NCT Number NCT07243158
Lead Sponsor Hangzhou Valgen Medtech Co., Ltd
Conditions Mitral Regurgitation Functional
Enrollment 148 participants
Start Date 2025-12-30
Primary Completion 2027-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-21